PRESS RELEASE
News
-
-
PRESS RELEASE
Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis
Abivax announces positive Phase 3 results for obefazimod in ulcerative colitis trials, meeting key endpoints and demonstrating favorable tolerability. Conference call scheduled for more insights -
-
PRESS RELEASE
Chiffre d'affaires annuel 2025 de 29,2 M EUR (c. 34 M EUR en intégration globale) Pipeline de croissance robuste Objectifs 2030 confirmés
La Française de l'Énergie affiche un chiffre d'affaires annuel de 29,2 M€ pour 2025, avec une croissance soutenue de l'activité gaz malgré les contraintes de réseau. Objectifs 2030 confirmés -
PRESS RELEASE
FY 2025 Annual Revenues Reached EUR 29.2m (over EUR 34m on a fully integrated basis) Solid Growth Pipeline in Place FY 2030 Objectives Confirmed
La Française de l'Énergie reports FY 2025 annual revenues of €29.2m, revenue stability despite declining electricity prices, strong growth pipeline for FY 2030, and optimization of financial structure -
-
PRESS RELEASE
DRONE VOLT announces a strategic acquisition and positions itself as a key player in drone-based LiDAR
DRONE VOLT acquires a LiDAR specialist to enhance its drone services, focusing on 3D modeling and high-value segments. The integration strengthens the company's offerings and expert network -
-
-
